Jane Street’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Jane Street’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,340	Closed	-$377K	–	5066
2016 Q4	$377K	Sell	30,340 -65,670	-68%	-$791K	﹤0.01%	3136
2016 Q3	$1.31M	Buy	96,010 +55,344	+136%	+$556K	0.01%	1628
2016 Q2	$301K	Buy	+40,666	New	+$305K	﹤0.01%	3318
2015 Q4	–	Sell	-104,652	Closed	-$611K	–	4780
2015 Q3	$611K	Buy	104,652 +62,151	+146%	+$479K	﹤0.01%	2100
2015 Q2	$351K	Sell	42,501 -75,967	-64%	-$672K	﹤0.01%	2644
2015 Q1	$976K	Buy	+118,468	New	+$876K	0.01%	1391
2014 Q3	–	Sell	-24,259	Closed	-$155K	–	3394
2014 Q2	$155K	Sell	24,259 -91,183	-79%	-$627K	﹤0.01%	2271
2014 Q1	$930K	Buy	115,442 +5,610	+5%	+$43.7K	0.01%	1022
2013 Q4	$749K	Buy	+109,832	New	+$593K	0.01%	946

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Jane Street's ARIA Position: Q1 2017 in Review

Jane Street sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,340 shares — an estimated $377K sold.

Jane Street first reported a position in ARIA in Q4 2013 and held it in 9 quarters. The position peaked at $1.31M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Jane Street reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Jane Street sold 30,340 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $377K.
Jane Street first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 9 quarters.
Jane Street's Ariad Pharmaceuticals Inc position peaked at $1.31M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Jane Street's 13F filing for Q1 2017, filed 15 May 2017.